|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2006-1-25
|
|
pubmed:abstractText |
Therapy of colorectal tumors (CRC) based on histology and clinical factors is insufficient to predict the evolution of each patient. The finding of molecular abnormalities able to differentiate subgroups of patients with bad prognosis will improve our ability to treat them successfully. Our purpose was to analyze retrospectively the prognostic input of E-cadherin, beta-catenin, metalloproteinases (MMPs) (7 and 9), and tissue inhibitors of metalloproteinases (TIMPs) (1 and 2) in patients with a follow-up period of 5 years.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0022-4790
|
|
pubmed:author |
pubmed-author:BonadeoFernandoF,
pubmed-author:LastiriJoséJ,
pubmed-author:MauroLaura VLV,
pubmed-author:MorandiAnaA,
pubmed-author:PallottaMaría GuadalupeMG,
pubmed-author:PuricelliLydia InésLI,
pubmed-author:QuintanaGuillermo OjeaGO,
pubmed-author:RocaFernandaF,
pubmed-author:SpectermanSergioS,
pubmed-author:VaccaroCarlosC,
pubmed-author:de Kier JofféElisa BalEB
|
|
pubmed:copyrightInfo |
(c) 2006 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
93
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
151-60
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16425303-Adult,
pubmed-meshheading:16425303-Aged,
pubmed-meshheading:16425303-Cadherins,
pubmed-meshheading:16425303-Colorectal Neoplasms,
pubmed-meshheading:16425303-Female,
pubmed-meshheading:16425303-Humans,
pubmed-meshheading:16425303-Male,
pubmed-meshheading:16425303-Matrix Metalloproteinases,
pubmed-meshheading:16425303-Middle Aged,
pubmed-meshheading:16425303-Multivariate Analysis,
pubmed-meshheading:16425303-Predictive Value of Tests,
pubmed-meshheading:16425303-Prognosis,
pubmed-meshheading:16425303-Proportional Hazards Models,
pubmed-meshheading:16425303-Retrospective Studies,
pubmed-meshheading:16425303-Survival Analysis,
pubmed-meshheading:16425303-Tissue Inhibitor of Metalloproteinase-1,
pubmed-meshheading:16425303-Tissue Inhibitor of Metalloproteinase-2,
pubmed-meshheading:16425303-Tissue Inhibitor of Metalloproteinases,
pubmed-meshheading:16425303-Tumor Markers, Biological,
pubmed-meshheading:16425303-beta Catenin
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Prognostic value of E-cadherin, beta-catenin, MMPs (7 and 9), and TIMPs (1 and 2) in patients with colorectal carcinoma.
|
|
pubmed:affiliation |
Research Area of the Institute of Oncology Angel H. Roffo, Buenos Aires, Argentina.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
